IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Esperion Therapeutics

CUSIP: 29664WAA3 | 2 institutional holders

Quarters

Q4 2021Q3 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2021

Silverback Asset Management LLC12,000,000
0.8% of portfolio›$6.5K
StyleTurnoverLocationFiled
Silverback Asset Management LLC
12,000,000$6.5K0.8%Agg GrowthMediumDurham, NC2022-02-14